Rapid determination of nematode cell and organ susceptibility to toxic treatments
Not Available
Jasmer, Douglas P.↗
SEARCH · Engineering Papers
Results for “treatment”
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Determining the Optimal Treatment of Locally Advanced Breast Cancer With Sequelae of Dermatomyositis
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Lung Mass With Massive Hemoptysis: Treatment Without Tissue Diagnosis
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Urgent, Urgent, Emergency: Treatment Without Tissue
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Erratum to: Sperduto PW, Mesko S, Li J, et al. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today. Int J Radiat Oncol Biol Phys 2020:107(2);334-343
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Prospective Phase 2 Study of Radiation Therapy Dose and Volume De-escalation for Elective Neck Treatment of Oropharyngeal and Laryngeal Cancer
The required elective nodal dose and volumes for head and neck intensity modulated radiation therapy have largely been extrapolated from conventional radiation therapy fields. In this prospective, dual-center, phase 2 study, we investigated the efficacy and tolerability of reduced elective nodal volume and dose in oropharyngeal and laryngeal squamous cell carcinoma.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer
Definitive radiation therapy (RT), with or without concurrent chemotherapy, is an alternative to radical cystectomy for patients with localized, muscle-invasive bladder cancer (MIBC) who are either not surgical candidates or prefer organ preservation. We aim to synthesize an evidence-based guideline regarding the appropriate use of RT.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Locoregional Treatments and Ipsilateral Breast Cancer Recurrence Rates in BRCA1/2 Mutation Carriers
There is a paucity of data on the rates of ipsilateral breast tumor recurrence (IBTR) in BRCA1/2–associated breast cancer (BC). Scarcer yet are outcomes data in BRCA1/2 mutation carriers in the setting of newer mastectomy techniques, such as skin-sparing mastectomies (SSM) and nipple-sparing mastectomies (NSM).
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder Cancer
Hypofractionated radiation therapy can be used to treat patients with muscle-invasive bladder cancer unable to have radical therapy. Toxicity is a key concern, but adaptive plan-of the day (POD) image-guided radiation therapy delivery could improve outcomes by minimizing the volume of normal tissue irradiated. The HYBRID trial assessed the multicenter implementation, safety, and efficacy of this strategy.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Association Between Patient Education Videos and Knowledge of Radiation Treatment
Patient knowledge of radiation therapy (RT) before consult is typically limited, with many having misconceptions or fears. There exists a need to improve patient education in RT. Our purpose was to study the impact of patient education videos on patient-reported knowledge of RT, anxiety/fear, and satisfaction.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer
This prospective phase 3 randomized trial was designed to test whether ultra high single-dose radiation therapy (24 Gy SDRT) improves local control of oligometastatic lesions compared to a standard hypofractionated stereotactic body radiation therapy regimen (3 × 9 Gy SBRT). The secondary endpoint was to assess the associated toxicity and the impact of ablation on clinical patterns of metastatic progression.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
A Tailored Radiation Therapy Strategy for Older Patients With Localized Bladder Cancer Not Eligible for Curative Treatment
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
ATM Variants in Breast Cancer: Implications for Breast Radiation Therapy Treatment Recommendations
Advances in germline genetic testing have led to a surge in identification of ataxia-telangiectasia mutated (ATM) variant carriers among breast cancer patients, raising numerous questions regarding use of breast radiation therapy (RT) in this population.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Treatment of WHO Grade 2 Meningiomas With Stereotactic Radiosurgery: Identification of an Optimal Group for SRS Using RPA
This study assesses a large multi-institutional database to present the outcomes of World Health Organization grade 2 meningiomas treated with stereotactic radiosurgery (SRS). We also compare the 3-year progression-free survival (PFS) to that reported in the Radiation Therapy Oncology Group 0539 phase 2 cooperative group meningioma trial.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Treatment Outcomes for Small Cell Carcinoma of the Bladder: Results From a UK Patient Retrospective Cohort Study
Small cell carcinoma of the bladder (SCCB) is rare, accounting for less than 1% of all bladder carcinomas. It is aggressive, and outcomes are poor as a result of its early metastatic spread. Owing to its rarity, there are limitations on data to propose standardized management pathways.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Psychological Treatment for Patients Receiving Radiation: Results of NRG Oncology/RTOG 0841
NRG/RTOG 0841 assessed the feasibility of a depression screening procedure in patients receiving radiation therapy (RT). As a secondary endpoint, availability and barriers to psychosocial care data were collected in hopes of providing recommendations for improved psychosocial care among patients receiving RT.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes
To analyze the 5-year biochemical disease-free survival (bDFS) and late toxicity profile in patients with prostate cancer treated with pencil beam scanning (PBS) proton radiation therapy.
62 RADIOLOGY AND NUCLEAR MEDICINE↗